Page last updated: 2024-08-18

thiophenes and zoledronic acid

thiophenes has been researched along with zoledronic acid in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (30.77)29.6817
2010's8 (61.54)24.3611
2020's1 (7.69)2.80

Authors

AuthorsStudies
Biskobing, DM; Downs, R; Novy, AM1
Geusens, P; Reid, D1
Delmas, PD; Vignot, E1
Fukawa, T; Kamiya, S; Wada, S1
Bolland, MJ; Gamble, GD; Grey, AB; Reid, IR1
Chen, B; Li, Y; Xie, D; Xu, H; Yang, X1
Bouvet, A; Caruba, T; Pouchot, J; Sabatier, B; Savoldelli, V1
Reid, IR1
Chen, LX; Feng, SQ; Li, YL; Ning, GZ; Zhang, D; Zhang, TS; Zhou, ZR1
Eiken, P; Vestergaard, P1
Dempster, DW; Moreira, CA1
Ding, GZ; Tao, ZS; Wang, L; Wu, XJ; Xie, JB; Xu, ZJ; Yang, M; Zhang, X; Zhou, WS1
Andreis, JD; Castro, ML; Claudino, M; Delfrate, G; Fischborn, AR; Franco, GCN; Mecca, LEA; Mroczek, T; Oliveira, FB; Rigo, NM; Taba Junior, M1

Reviews

6 review(s) available for thiophenes and zoledronic acid

ArticleYear
Novel therapeutic options for osteoporosis.
    Current opinion in rheumatology, 2002, Volume: 14, Issue:4

    Topics: Animals; Controlled Clinical Trials as Topic; Diphosphonates; Disease Models, Animal; Evidence-Based Medicine; Fractures, Spontaneous; Glycoproteins; Humans; Ibandronic Acid; Imidazoles; Norpregnenes; Osteoporosis; Osteoprotegerin; Piperidines; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Selective Estrogen Receptor Modulators; Thiophenes; Zoledronic Acid

2002
Newer drug treatments: their effects on fracture prevention.
    Best practice & research. Clinical rheumatology, 2005, Volume: 19, Issue:6

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bone Density; Bone Density Conservation Agents; Calcitonin; Denosumab; Diphosphonates; Fractures, Bone; Glycoproteins; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ibandronic Acid; Imidazoles; Organometallic Compounds; Osteoporosis; Osteoprotegerin; Parathyroid Hormone; RANK Ligand; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Thiophenes; Zoledronic Acid

2005
[Newly developed drugs for osteoporosis in overseas and their future roles for the therapy].
    Clinical calcium, 2008, Volume: 18, Issue:10

    Topics: Anabolic Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Bone Resorption; Denosumab; Diphosphonates; Drug Design; Evidence-Based Medicine; Fractures, Bone; Humans; Imidazoles; Indoles; Organometallic Compounds; Osteoporosis; RANK Ligand; Selective Estrogen Receptor Modulators; Teriparatide; Thiophenes; Zoledronic Acid

2008
Effect of osteoporosis treatment on mortality: a meta-analysis.
    The Journal of clinical endocrinology and metabolism, 2010, Volume: 95, Issue:3

    Topics: Age Factors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Denosumab; Diphosphonates; Etidronic Acid; Fractures, Bone; Humans; Imidazoles; Organometallic Compounds; Osteoporosis; Randomized Controlled Trials as Topic; RANK Ligand; Risedronic Acid; Thiophenes; Treatment Outcome; Zoledronic Acid

2010
Comparison of Bone Mineral Density in Lumbar Spine and Fracture Rate among Eight Drugs in Treatments of Osteoporosis in Men: A Network Meta-Analysis.
    PloS one, 2015, Volume: 10, Issue:5

    Topics: Alendronate; Bone Density; Bone Density Conservation Agents; Diphosphonates; Fractures, Bone; Humans; Hydroxycholecalciferols; Ibandronic Acid; Imidazoles; Lumbar Vertebrae; Osteoporosis; Parathyroid Hormone; Risedronic Acid; Teriparatide; Thiophenes; Zoledronic Acid

2015
Treatment of osteoporosis after alendronate or risedronate.
    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2016, Volume: 27, Issue:1

    Topics: Alendronate; Bone Density Conservation Agents; Diphosphonates; Drug Substitution; Female; Humans; Imidazoles; Osteoporosis, Postmenopausal; Risedronic Acid; Teriparatide; Thiophenes; Zoledronic Acid

2016

Other Studies

7 other study(ies) available for thiophenes and zoledronic acid

ArticleYear
[Advances in the field of osteoporosis].
    La Revue du praticien, 2007, Oct-15, Volume: 57, Issue:15

    Topics: Absorptiometry, Photon; Adult; Bone Density; Bone Density Conservation Agents; Child; Diphosphonates; Female; Glucocorticoids; Humans; Hypogonadism; Imidazoles; Male; Middle Aged; Organometallic Compounds; Osteoporosis; Teriparatide; Thiophenes; Zoledronic Acid

2007
Zoledronic acid enhances bone-implant osseointegration more than alendronate and strontium ranelate in ovariectomized rats.
    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2013, Volume: 24, Issue:7

    Topics: Alendronate; Animals; Bone Density; Bone Density Conservation Agents; Diphosphonates; Drug Evaluation, Preclinical; Female; Femur; Humans; Imidazoles; Materials Testing; Orthopedic Fixation Devices; Osseointegration; Osteoporosis, Postmenopausal; Ovariectomy; Prostheses and Implants; Rats; Stress, Mechanical; Thiophenes; Tibia; Titanium; Zoledronic Acid

2013
Evaluation of the prescription of osteoporosis treatment after a major osteoporotic fracture.
    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2014, Volume: 20, Issue:6

    Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Calcium; Dietary Supplements; Diphosphonates; Female; Follow-Up Studies; Fractures, Bone; France; Hip Fractures; Humans; Imidazoles; Male; Middle Aged; Osteoporosis; Osteoporotic Fractures; Prescriptions; Raloxifene Hydrochloride; Retrospective Studies; Thiophenes; Treatment Outcome; Vitamin D; Wrist Injuries; Zoledronic Acid

2014
Efficacy, effectiveness and side effects of medications used to prevent fractures.
    Journal of internal medicine, 2015, Volume: 277, Issue:6

    Topics: Alendronate; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Calcium Compounds; Denosumab; Diphosphonates; Etidronic Acid; Evidence-Based Medicine; Hip Fractures; Humans; Ibandronic Acid; Imidazoles; Osteoporosis; Osteoporotic Fractures; Raloxifene Hydrochloride; Risedronic Acid; Risk Assessment; Spinal Fractures; Teriparatide; Thiophenes; Treatment Outcome; Vitamin D; Zoledronic Acid

2015
Histomorphometric changes following treatment for osteoporosis.
    Journal of endocrinological investigation, 2017, Volume: 40, Issue:9

    Topics: Anabolic Agents; Bone and Bones; Bone Density; Bone Density Conservation Agents; Bone Remodeling; Clinical Trials as Topic; Humans; Osteoporosis; Teriparatide; Thiophenes; Treatment Outcome; Zoledronic Acid

2017
Prevention of ovariectomy-induced osteoporosis in rats : Comparative study of zoledronic acid, parathyroid hormone (1-34) and strontium ranelate.
    Zeitschrift fur Gerontologie und Geriatrie, 2019, Volume: 52, Issue:2

    Topics: Animals; Bone Density Conservation Agents; Female; Osteoporosis; Ovariectomy; Parathyroid Hormone; Rats; Rats, Sprague-Dawley; Thiophenes; X-Ray Microtomography; Zoledronic Acid

2019
Absence of medication-related jaw osteonecrosis after treatment with strontium ranelate in ovariectomized rats.
    Brazilian oral research, 2022, Volume: 36

    Topics: Animals; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Diphosphonates; Female; Osteonecrosis; Rats; Thiophenes; Tooth Extraction; Zoledronic Acid

2022